Vivitrol is available through our MAT services at the following Mountainside locations: Canaan, CT, Wilton,CT, Chappaqua, NY, Huntington, NY, and Ramsey, NJ.
Vivitrol is a once-monthly extended-release injectable formulation of naltrexone. It is administered by healthcare professionals as part of alcohol and opioid addiction treatment. It should be taken as part of comprehensive Medication-Assisted Treatment.
Opioids, also known as narcotics, are legal and illegal drugs that interact with the nervous system to relieve pain. Most commonly abused opioids are heroin, morphine, and prescription painkillers like Demerol, OxyContin, and Vicodin.
Naltrexone, the active ingredient in Vivitrol, works by blocking natural opiate receptors in the brain that normally register the sensations caused by opioid drugs and alcohol. It eliminates or substantially reduces cravings one month at a time, allowing individuals to focus on their treatment.
While both are used to treat alcohol and opioid addiction, naltrexone pills must be taken daily. If an individual does not have the necessary self-discipline or has a busy schedule, they could miss a dose, putting their recovery at risk. Vivitrol injections last a month, and therefore reduce this risk.
Vivitrol is for individuals who are struggling with alcohol or opioid addiction and need some extra assistance to remain focused on their recovery. Because Vivitrol only needs to be administered once a month, it is ideal for individuals with busy lifestyles and those not inpatient rehab. Vivitrol allows them the opportunity to receive addiction treatment on a schedule that works for them. It is also an option for those who are currently on a methadone or buprenorphine regimen and would like to come off those medications.
Individuals must be opioid and alcohol-free for a minimum of seven to ten days prior to beginning Vivitrol treatment.
No, there is unfortunately no cure for alcoholism or opioid addiction. Both are chronic diseases that require constant care and a strong support network to prevent relapse. Vivitrol is a proven medication that can help individuals stay focused and engaged in their recovery, especially during the early stages when triggers and negative influences can challenge their sobriety.
Some of the most common side-effect of taking Vivitrol include: anxiety, dizziness, drowsiness, fatigue, headaches, nausea, loss of appetite, and pain at the injection site. Although serious side-effects are rare, it is important to only take Vivitrol in a rehab setting or under medical supervision.
No, Vivitrol is non-addictive. It is not a narcotic and will not produce dependence on opioids or alcohol. When Vivitrol treatment is stopped, there will not be any withdrawal effects.
It is highly unlikely that an individual will overdose if they are being administered Vivitrol by a medical professional. However, opioid overdoses are more likely, as Vivitrol reduces an individual’s tolerance. If an individual takes a high number of opioids to overcome the blockade created by Vivitrol, a lethal overdose can occur. Similarly fatal outcomes have been reported in individuals who used opioids at the end of a dosing interval, after missing a scheduled dose, or after discontinuing Vivitrol treatment. It is crucial that individuals on Vivitrol understand the dangers of taking opioids while on the medication.
Vivitrol is available through our MAT services at the following Mountainside locations: Canaan, CT, Wilton,CT, Chappaqua, NY, Huntington, NY, and Ramsey, NJ.
Medication-Assisted Treatment has been proven to be a key tool in helping to fight the opioid crisis. To learn more about how it can help an individual’s addiction treatment, watch this short video.
Certain individuals need some extra help to stay on the path to recovery. For many, Vivitrol can help. In this short video, learn more about the benefits of Vivitrol and how it can strengthen your recovery.
The medications Vivitrol and Suboxone are similarly efficient forms of addiction treatment. Learn about their effects and the key differences between them.